-
digital.ahrq.gov/ahrq-funded-projects/health-information-technology-and-improving-medication-use/annual-summary/2010
January 01, 2010 - and Women's Hospital
Funding Mechanism
RFA: HS07-004: Centers for Education and Research on Therapeutics … Target Population: General
Summary: The Centers for Education and Research on Therapeutics … of clinical decision support and automated telephone outreach on antihypertensive and lipid-lowering therapy … Project 2: A Multi-Modal Intervention to Improve Antihypertensive and Lipid-Lowering Therapy. … semi-structured informational interviews with primary care physicians to understand care gaps in the treatment
-
psnet.ahrq.gov/node/49611/psn-pdf
October 01, 2010 - psychiatrists.(3,4) In one epidemiologic survey, specialists
in mental and addictive disorders provided treatment … If there is no
response by 8 to 12 weeks at a maximum therapeutic dose, the patient should be given … patient is interested in understanding the depression or
initiating psychotherapy; and in cases of treatment-resistant … Clinical Practice Guideline Number 5: Depression in Primary
Care, Volume 2: Treatment of Major Depression … Pharmacologic treatment of acute major depression and
dysthymia.
-
digital.ahrq.gov/health-care-theme/medication-reconciliation
January 01, 2023 - Medication Use
Description
This project was one of the Centers for Education and Research on Therapeutics … national initiative to increase awareness of the benefits and risks of new, existing, or combined uses of therapeutics
-
digital.ahrq.gov/health-it-tools-and-resources/workflow-assessment-health-it-toolkit/research/margalit-rs-et-al-2006
January 01, 2006 - r = -.30, p < .10), while keyboarding increased biomedical exchange, including more questions about therapeutic … Physicians who spent more time keyboarding also asked more specific questions about their patients' therapeutic
-
psnet.ahrq.gov/node/45455/psn-pdf
June 29, 2017 - jama-professionalism-disclosure-medical-error
Disclosing medical errors to patients is essential for maintaining a therapeutic
-
psnet.ahrq.gov/node/40079/psn-pdf
December 18, 2014 - medication-overdoses-leading-emergency-department-visits-among-children
https://psnet.ahrq.gov/issue/therapeutic-errors-among-children-community-setting-nature-causes-and-outcomes
-
psnet.ahrq.gov/node/38448/psn-pdf
March 04, 2009 - The authors suggest that future preventive strategies focus on the subset of therapeutic errors,
which
-
psnet.ahrq.gov/node/46246/psn-pdf
June 25, 2018 - Prior studies demonstrate that disclosure of medical errors to patients is central to maintaining a
therapeutic
-
psnet.ahrq.gov/node/33925/psn-pdf
December 18, 2008 - They concluded that with the reductions in
negative therapeutic outcomes, pharmaceutical care can avoid
-
digital.ahrq.gov/ahrq-funded-projects/health-information-technology-and-improving-medication-use/annual-summary/2011
January 01, 2011 - and Women's Hospital
Funding Mechanism
RFA: HS07-004: Centers for Education and Research on Therapeutics … 2012
AHRQ Funding Amount
$1,999,073
Summary: The Centers for Education and Research on Therapeutics … of clinical decision support and automated telephone outreach on antihypertensive and lipid-lowering therapy … Project 2: A Multi-Modal Intervention to Improve Antihypertensive and Lipid-Lowering Therapy . … informational interviews using an interview script with primary care physicians to understand care gaps in the treatment
-
psnet.ahrq.gov/node/45460/psn-pdf
September 14, 2016 - the growing role of pharmacists in counseling high-
risk patients, discharge medication counseling, therapeutic
-
psnet.ahrq.gov/node/45159/psn-pdf
June 15, 2016 - that contribute to this epidemic and clarifies current evidence
to address misunderstandings about therapeutic … The
authors suggest enhanced use of monitoring mechanisms and alternative therapies to promote safer
-
psnet.ahrq.gov/node/43481/psn-pdf
December 23, 2016 - reports on new standards for tubing
connectors to prevent injury from incorrect administration of therapeutic
-
psnet.ahrq.gov/node/40477/psn-pdf
March 23, 2012 - psnet.ahrq.gov/issue/adverse-drug-events-ambulatory-care
https://psnet.ahrq.gov/issue/unintentional-therapeutic-errors-involving-insulin-ambulatory-setting-reported-poison-centers
-
psnet.ahrq.gov/node/36928/psn-pdf
September 09, 2011 - 15% of which resulted in clinical
consequences (ie, the need for additional patient monitoring or therapeutic
-
hcup-us.ahrq.gov/db/nation/neds/stats/NEDS_2015Q1Q3_IP_MaskedStats.PDF
October 01, 2014 - W MCC 3,509 0.11
920: COMPLICATIONS OF TREATMENT W CC 4,674 0.15
921: COMPLICATIONS OF TREATMENT W … W MCC 3,523 0.11
920: COMPLICATIONS OF TREATMENT W CC 4,676 0.15
921: COMPLICATIONS OF TREATMENT W … procedures 13,569 0.43
4: Major Therapeutic - Operating room therapeutic procedures 456,449 14.36 … 5,956 0.19
146: Treatment; fracture or dislocation of hip and femur 38,788 1.22
147: Treatment; fracture … 1,958 0.06
212: Diagnostic physical therapy 755 0.02
213: Physical therapy exercises; manipulation
-
digital.ahrq.gov/care-setting/pharmacy
January 01, 2023 - Enhancing Clinical Decision Support Applications for Community Pharmacist-Delivered Medication Therapy … Management
Description
This research evaluated the usability and usefulness of medication therapy … Medication Use
Description
This project was one of the Centers for Education and Research on Therapeutics … national initiative to increase awareness of the benefits and risks of new, existing, or combined uses of therapeutics
-
psnet.ahrq.gov/web-mm/novel-drug-misuse
September 30, 2010 - Ensuring appropriate use of novel and potentially toxic therapeutics is a challenging endeavor. … FDA-approved labeling indications help to guide clinicians in the use of a new therapeutic agent. … While these concepts apply to any novel therapeutic, specific issues surround the use of high-cost biopharmaceutical … Applying patient selection criteria for drotrecogin alfa therapy in practice. … Applying patient selection criteria for drotrecogin alfa therapy in practice.
-
psnet.ahrq.gov/node/49454/psn-pdf
July 01, 2004 - FDA-
approved labeling indications help to guide clinicians in the use of a new therapeutic agent. … While these concepts apply to any novel therapeutic, specific issues surround the use of high-cost
biopharmaceutical … Ensuring appropriate use of novel and potentially toxic therapeutics is a challenging endeavor that … Applying patient selection criteria for drotrecogin alfa
therapy in practice. … Applying patient
selection criteria for drotrecogin alfa therapy in practice.
-
psnet.ahrq.gov/web-mm/suicidal-man-gun
May 01, 2005 - Even with the truncated information presented in this case, I believe that the therapeutic impasse and … A clinician hearing such an admission should wonder whether this was “a cry for help” to test the therapeutic … alliance and may not be a suitable candidate for therapy. … Removing the gun before initiating treatment might have allowed the therapeutic alliance to develop. … Inevitably, this approach ends in futility for the therapist, dooming the therapy.